Seven years ago, my husband and I owned a Mustang GT. A black one with black leather interior. Our car was clean and waxed and clear of clutter. It was small and sporty and we loved it. Others loved it. We were cool. We thought so, anyway.

We don't think we are so cool now, however. We are happy, with our two children, our dented and dirty Honda Odyssey mini-van, and all the gear -- books, toys, wet wipes, a scooter, a Big Wheel, and even a little potty -- that fills the vast space of our latest vehicle. But I am not sure anyone would ever call us cool as we cruise around town in our family ride.

My husband, John, dreams of getting another Mustang. And he's primed our three-year-old son for the same dream. Danny can spot a Mustang a mile away, regardless of its year, its color, or its condition. He loves a rag-top. He prefers yellow. And he promises to buy his daddy a black Mustang as soon as he wins the lottery.

I told John last night that Ford is about to release a new Mustang, with both the exterior paint and interior stitching trimmed in pink. "Let's get it," John said, without hesitation. He isn't worried he'll look less than macho in a pink Mustang. He just wants one. And while his intentions faded a bit when he learned Ford will offer only V6 models, he still thinks a pink pony car is a cool concept.

Not everyone likes the idea of a Mustang marketed at women, says analyst Erich Merkle of IRN Inc. in Grand Rapids who adds that the Mustang is an iconic brand based on a special mix of speed and testosterone. Ford should not mess with success, he believes.

But Ford expects its Warriors in Pink trim package, slated to release this summer, to be nothing short of a success -- in more ways than one.

A portion of Mustang profits will be donated to Susan G. Komen for the Cure for breast cancer research. Ford has long been a sponsor of this organization and over the years has donated $87 million. In addition, the pink initiative could attract new buyers to the car, marked by slipping sales in recent months.

While all details have not been released, the newest Mustang will be available in a few colors, and customers will have the choice of convertible or hardtop.

Researchers are beginning to tell us that being overweight increases cancer risks for a number of cancers. But then being overweight increases our chances of developing a number of diseases. While there are all kinds of diets, and gurus who claim they know the way, the remedy for long-term weight loss isn't going to change -- it's all about moving more, and eating less.

But what if you are moving more and eating less and the pounds stubbornly refuse to fall away? Amy Paturel, an expert in nutrition and public health, recently reviewed the top ten reasons why when you do all the right things, you aren't getting the expected results. The ten reasons Paturel discusses that can prevent weight loss are lack of sleep, synthetic chemicals in the environment, weather effects in temperatures being too hot or too cold, not smoking, prescription medications, giving birth at an older age, natural selection and overweight parents having overweight children.

Of course, this doesn't mean you are doomed to weight gain or being overweight but it might mean that you will need to take a look at some of the possible causes of why you are experiencing weight gain and not experiencing weight loss.

Paturel goes into an explanation of each of these causes in Ten More Fat Factors: It's Not Just the Cupcakes.

I think obesity will always carry with it a risk for health problems. And according to a new study released on Monday, men with prostate cancer who are overweight have a higher risk of tumor recurrence after radiation treatment than thinner men do. Specifically, moderately and severely overweight men had a 70 percent higher risk of recurrence than men who were not overweight -- as indicated by rising levels of PSA, a blood protein that can signal prostate cancer. It is not clear how exactly obesity affects the success of radiation treatment -- perhaps it's the fat tissue that secretes certain hormones that helps the cancer progress at a later time. Regardless, the study suggests that men who are overweight do not fare as well as those who are at an average weight -- and this gives men a definite reason to trim down.

Obesity in this study was characterized by body mass index -- BMI -- a statistic that takes into account height and weight. A man five feet, 10 inches tall would be considered normal weight at or below 184 pounds. He would be overweight at 185 to 209 pounds, mildly obese at 210 to 244 pounds, and moderately to severely obese at above 244 pounds. Moderately to severely obese men had almost twice the risk of developing elevated PSA levels, according to an epidemiologist who led research in the study -- which will be published in the August 1 issue of the scientific journal Cancer.